Skip to main content
. 2024 Feb 27;7(2):e240407. doi: 10.1001/jamanetworkopen.2024.0407

Figure 1. Association of Tumor-Stroma Proportion (TSP) and Clinical Outcomes in Patients With Ovarian Cancer in the The Cancer Genome Atlas (TCGA) Cohort.

Figure 1.

The figure shows representative images (A) of stroma-rich (high TSP [TSP = 1]) and stroma-poor (low TSP [TSP = 0]) specimens in the TCGA cohort. S indicates the stromal component within the tumor; T, cancerous cells within the specimen. The Kaplan-Meier curves show progression-free survival (B) in patients with low TSP vs high TSP (HR, 1.661; 95% CI, 0.766-3.603) and overall survival (C) in patients with low TSP vs high TSP (HR 1.906; 95% CI, 0.962-3.776 95%).